XML 24 R7.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 3 Months Ended
Apr. 01, 2018
Apr. 02, 2017
CASH FLOWS FROM OPERATING ACTIVITIES    
Net earnings $ 4,367 $ 4,422
Adjustments to reconcile net earnings to cash flows from operating activities:    
Depreciation and amortization of property and intangibles 1,746 912
Stock based compensation 268 229
Asset write-downs 0 37
Deferred tax provision 44 (27)
Accounts receivable allowances (20) (13)
Changes in assets and liabilities, net of effects from acquisitions and divestitures:    
Increase in accounts receivable (479) (96)
Increase in inventories (322) (368)
Decrease in accounts payable and accrued liabilities (1,686) (2,030)
Increase in other current and non-current assets (907) (424)
Increase in other current and non-current liabilities 595 271
NET CASH FLOWS FROM OPERATING ACTIVITIES 3,606 2,913
CASH FLOWS FROM INVESTING ACTIVITIES    
Additions to property, plant and equipment (658) (560)
Proceeds from the disposal of assets/businesses, net 20 31
Acquisitions, net of cash acquired (82) (4,852)
Purchases of investments (548) (4,550)
Sales of investments 341 8,994
Other 2 1
NET CASH USED BY INVESTING ACTIVITIES (925) (936)
CASH FLOWS FROM FINANCING ACTIVITIES    
Dividends to shareholders (2,253) (2,171)
Repurchase of common stock (1,444) (3,342)
Proceeds from short-term debt 26 719
Retirement of short-term debt (2,484) (195)
Proceeds from long-term debt, net of issuance costs 2 4,464
Retirement of long-term debt (8) (2)
Proceeds from the exercise of stock options/employee withholding tax on stock awards, net 66 402
Other 125 (25)
NET CASH USED BY FINANCING ACTIVITIES (5,970) (150)
Effect of exchange rate changes on cash and cash equivalents 104 110
(Decrease)/Increase in cash and cash equivalents (3,185) 1,937
Cash and Cash equivalents, beginning of period 17,824 18,972
CASH AND CASH EQUIVALENTS, END OF PERIOD 14,639 20,909
Acquisitions    
Fair value of assets acquired 119 5,250
Fair value of liabilities assumed and noncontrolling interests (37) (398)
Net cash paid for acquisitions $ 82 $ 4,852